Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-oesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Active Not RecruitingNCT02678182
What this trial is testing

Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial

Who this might be right for
Adenocarcinoma of the OesophagusAdenocarcinoma of the Gastro-oesophageal JunctionAdenocarcinoma of the Stomach
Royal Marsden NHS Foundation Trust 494
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Large-scale testing (Phase 3)Active Not RecruitingNCT03504397
What this trial is testing

Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Study completedNCT03409848
What this trial is testing

Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric Adenocarcinoma

Who this might be right for
Gastric CancerEsophageal CancerAdenocarcinoma Gastric+3 more
AIO-Studien-gGmbH 97
Early research (Phase 1)Active Not RecruitingNCT04044859
What this trial is testing

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Who this might be right for
Endometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more
USWM CT, LLC 120
Not applicableUnknownNCT04713059
What this trial is testing

Toripalimab Combined With Anlotinib for Patients With Advanced, Relapsed, or Refractory Gastric, or Esophagogastric Junction Cancer (EGJC)

Who this might be right for
Gastric or Gastro-oesophageal Junction CarcinomaAdvanced, Relapsed Gastric or Gastro-oesophageal Junction CarcinomaSecond-line Therapy
The Affiliated Hospital of Qingdao University 62
Not applicableEnded earlyNCT00341523
What this trial is testing

Early Detection of Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsEndoscopy, Gastrointestinal+2 more
National Cancer Institute (NCI) 6,864
Testing effectiveness (Phase 2)Study completedNCT02096666
What this trial is testing

A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects

Who this might be right for
Stomach Neoplasms
Amgen 11
Not applicableStudy completedNCT03102229
What this trial is testing

Real-time Activity Monitoring to Prevent Admissions During RadioTherapy

Who this might be right for
Cancer of the Head and NeckCancer of LungCancer of Esophagus+1 more
Montefiore Medical Center 40
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Study completedNCT05538195
What this trial is testing

Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+2 more
Chongqing Precision Biotech Co., Ltd 17
Not applicableLooking for participantsNCT06693622
What this trial is testing

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Who this might be right for
Gastro Esophageal Reflux DiseaseBarrett Esophagus
University of Colorado, Denver 556
Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Testing effectiveness (Phase 2)Study completedNCT00583674
What this trial is testing

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Who this might be right for
Gastrointestinal Cancer
Amgen 171
Not applicableUnknownNCT01438385
What this trial is testing

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Who this might be right for
Ampullary CancerDuodenal CancerBile Duct Cancer+20 more
Weill Medical College of Cornell University 12,000
Testing effectiveness (Phase 2)Study completedNCT03064490
What this trial is testing

Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)

Who this might be right for
Locally Advanced Esophageal and Gastric Cancers (EGC)
Duke University 35
Large-scale testing (Phase 3)UnknownNCT01786278
What this trial is testing

Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer

Who this might be right for
Adenocarcinoma of the Esophago-gastric Junction
Medical University of Lublin 80
Testing effectiveness (Phase 2)Study completedNCT00130689
What this trial is testing

Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer

Who this might be right for
Esophageal CancerGastric CancerNeoplasm Metastasis
Dana-Farber Cancer Institute 43
Testing effectiveness (Phase 2)Study completedNCT00591123
What this trial is testing

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Who this might be right for
Unresectable Adenocarcinoma of the EsophagusMetastatic Adenocarcinoma of the EsophagusUnresectable Adenocarcinoma of Gastric Cardia+1 more
Translational Oncology Research International 38
Next Page
565